Carlo Incerti

Insider Reports History

Entity
Individual
Location
Forbion Capital Fund IV Cooperaitef U.A., Goomier 2 35, Naarden, Netherlands
Signature
/s/ Richard Scalzo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carlo Incerti:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. Director Common Stock 0 $0 $28.73 Nov 18, 2024 Direct
Dyne Therapeutics, Inc. Director Stock option (right to buy) 22.7K Nov 18, 2024 Direct

Insider Reports Filed by Carlo Incerti

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DYN Dyne Therapeutics, Inc. Nov 18, 2024 3 -$331K 4 Nov 18, 2024 Director
DYN Dyne Therapeutics, Inc. May 22, 2024 1 $0 4 May 24, 2024 Director
DYN Dyne Therapeutics, Inc. May 24, 2023 1 $0 4 May 25, 2023 Director
DYN Dyne Therapeutics, Inc. Mar 2, 2022 1 $0 4 Mar 4, 2022 Director
DYN Dyne Therapeutics, Inc. Mar 2, 2022 0 $0 3 Mar 4, 2022 Director